This is a Frankfurt news story, published by Yahoo Finance, that relates primarily to Novo news.
For more Frankfurt news, you can click here:
more Frankfurt newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
profit growth. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest sales growth news, Novo news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
sales forecastReuters
•78% Informative
Operating profit in the quarter rose 8% at constant exchange rates to 25.9 billion Danish crowns ( $3.8 billion ) compared with the 27.3 billion forecast by analysts in a LSEG poll.
Novo 's Frankfurt -listed shares fell 3.2% just after market opening.
The company raised its 2024 sales forecast but trimmed profit outlook.
VR Score
89
Informative language
95
Neutral language
46
Article tone
formal
Language
English
Language complexity
52
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links